Vaccine Equity and the Universal Immunisation Programme: Insights from Dr. Gagandeep Kang

Dr. Gagandeep Kang, a leading figure in groundbreaking research on the effectiveness of the Rotovac vaccine, stresses the significance of achieving vaccine equity through the Universal Immunisation Programme in India. As the principal investigator in the phase III trials of the Rotovac vaccine, she expresses her excitement over the publication of study results confirming its efficacy in preventing rotavirus-related gastroenteritis. According to Kang, evidence-based vaccination strategies are crucial for combating infectious diseases, particularly in countries like India where access to vaccines can be challenging. She emphasizes the need for equitable distribution of vaccines to ensure that all populations have access to lifesaving immunization.